ATTEND THE CONGRESS

AND DISCUSS MS IN A GLOBALIZED AND DIGITAL WORLD

SPEAKERS

Allan Kermode

Professor Allan Kermode graduated from the University of Western Australia, is a fellow of the Royal Australasian College of Physicians and the Royal College of Physicians (London) and has worked in the Oxford University Department of Neurology and the Institute of Molecular Medicine, The National Hospital for Neurology and Neurosurgery, Queen Square, United Kingdom, the Heidelberg Kopfklinic, and in the National Institutes of Health, United States of America.

He has received numerous undergraduate and postgraduate awards and was an NHMRC CJ Martin Scholar.

Professor Kermode is currently Head of Department of Neurology at Sir Charles Gairdner Hospital and the Western Australian Neuromuscular Research Institute (WANRI), is the Clinical Professor of Neuroimmunology at Murdoch University and the Institute of Immunology and Infectious Diseases, and is a Clinical Professor of Neurology at the University of Western Australia.

Angelo Ghezzi

Angelo Ghezzi is the responsible of scientific research at Centro Studi Sclerosi Multipla-St Antonio Abate Hospital in Gallarate, Italy, the oldest Italian multiple sclerosis (MS) centre.

Dr. Ghezzi’s research has focused on the areas of: optic neuritis; MS and pregnancy; MS and sexual disturbances; MS and epilepsy; MS evolution and prognosis; MRI and clinical correlation with MS; and clinical neurophysiology (evoked potentials, pelvic floor neurophysiology). However, he is especially interested in the clinical and therapeutic aspects of paediatric MS (MS onset in childhood-adolescence, immunomodulatory treatment of juvenile-onset MS).

Dr. Ghezzi has edited 10 books on MS and has authored or co-authored of about 300 articles published in international journals. He has been an active researcher, serving as an investigator in many international clinical trials. He is a member of the International Pediatric MS Study Group, of the Italian MS Study Group of the Italian Neurological Society, and the IPedMS (Italian Pediatric MS)

Mark Keegan

Dr. Keegan trained in Neurology at the University of Saskatchewan in Saskatoon, Canada. He then completed two years subspecialty fellowship in Neuroimmunology and Multiple Sclerosis at Mayo Clinic in Rochester Minnesota. He joined the faculty of the Mayo Clinic in 2001 where he is a Consultant, Professor of Neurology and Head of the Division of Multiple Sclerosis and Autoimmune Neurology.

His research is published in high quality journals including Lancet, Brain, Neurology, Annals of Neurology and JAMA Neurology concentrates on progressive forms of multiple sclerosis, plasma exchange for severe attacks of MS and diagnosis of MS and its mimickers. His book Common Pitfalls in Multiple Sclerosis and CNS Demyelinating Diseases was recently published by Cambridge University Press.

Bassam Yamout

Dr. Yamout is currently Professor of neurology at the American University of Beirut Medical Center. He received his training in neurology at the University of Cincinnati-Ohio followed by a fellowship at the Montreal Neurological Institute-McGill University. He is currently head of clinical research at the Multiple Sclerosis Center, president of MENACTRIMS, fellow of the American Academy of Neurology, and member of multiple regional and intercontinental advisory boards for MS.

Dr Yamout is one of the leading experts on multiple sclerosis in the Middle East with recent research on epidemiology, quality of life of patients in the Middle East, novel therapies such as stem cells and venous stenosis, and the impact of wars on MS. In addition he is currently the principal investigator on several ongoing international MS trials. Dr Yamout has authored many research and review papers and is currently Chief Editor of the MS newsletter “MS today”, and on the editorial board of “Multiple Sclerosis and Related Disorders”.

Jürg Kesselring

-Professor of Clinical Neurology and Neurorehabilitation, University of Bern, Lecturer in Clinical Neuroscience Center of Neuroscience, University and ETH Zrich, chair of neurorehabilitation, San Raffaele University, Milano, Italy (2000-2011)
-Member of the Assembly of the International Committee of the Red Cross (ICRC)
-Fellow Royal College of Physicians (London)
-First Honorary President of the Swiss Multiple Sclerosis Society 2015, President 2005 – 2011, Vicepresident 1991 – 2005; 1985 – 2001 President, 1982 1985 Secretary of the Medical Advisory Board
-Lifetime Honorary Board Member Multiple Sclerosis International Federation (MSIF)
-Honorary Visiting Professor University of Melbourne, Australia 2014, 2015 & 2016
Margrit Egnr Prize 2015 “for outstanding achievements in anthropological philosophy and psychology”
-Chairman of the International Medical and Scientific Board of Multiple Sclerosis International Federation (MSIF) and of the Resarch Committee on Demyelination of the World Federation of Neurology (WFN), Chairman of the WHO Working Group on Multiple Sclerosis (1997 – 2005)
President of the European Committee on Treatment and Research in Multiple Sclerosis (ECTRIMS) 1990/91 and 1995 –1999
Honorary Senior Research Fellow: Institute of Neurology
The National Hospital, Queen Square, London (1983, 1987/8, 1993, 1998)
180 Original publications and Editor or Co-Autor of 15 books, mainly related to Multiple Sclerosis, Neurorehabilitation, Magnetic Resonance Imaging. 52 book chapters on various topics

Wallace Brownlee

Dr Wallace Brownlee
is an MS Specialist Neurologist and MS researcher at Queen Square MS Centre,
UCL Institute of Neurology, London, United Kingdom.

He completed medical
training and residency in Auckland, New Zealand before moving to London in 2013
to complete a PhD under the supervision of Prof David Miller and Prof Olga
Ciccarelli.

His research focuses on identification of early MRI predictors of
long term disease course in people with clinically isolated syndromes and the
use of advanced MRI to understand the mechanisms responsible long term
disability and secondary progression in relapse-onset MS. He is social media
editor for Multiple Sclerosis Journal.

Kazuo Fujihara

Kazuo Fujihara, M.D.is Professor, Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, and Director, Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama, Japan. Dr. Fujihara is a neurologist and has mainly worked in the field of multiple sclerosis (MS), neuromyelitis optica (NMO) and related neuroimmunological disorders. He is a member of the International Panel on Diagnosis of MS (the 2010 and 2016 revisions to the McDonald Criteria) and the International Panel on NMO Diagnosis (the 2015 International Consensus Diagnostic Criteria of NMOSD).

Since 2013, he has served on the Executive Committee, International Medical and Scientific Board of The Multiple Sclerosis International Federation (MSIF), and the Board of European Charcot Foundation (ECF). He is an inaugural member and Deputy Secretary of Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS) and an honorary member of The Association of Sri Lankan Neurologists (Honorary Member, 2012), Indian Academy of Neurology (Honorary Corresponding Member, 2015) and Hong Kong Society of Multiple Sclerosis (Honorary Fellow, 2015).

Irati Zubizarreta

Kazuo Fujihara, M.D.is Professor, Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, and Director, Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama, Japan. Dr. Fujihara is a neurologist and has mainly worked in the field of multiple sclerosis (MS), neuromyelitis optica (NMO) and related neuroimmunological disorders. He is a member of the International Panel on Diagnosis of MS (the 2010 and 2016 revisions to the McDonald Criteria) and the International Panel on NMO Diagnosis (the 2015 International Consensus Diagnostic Criteria of NMOSD).

Since 2013, he has served on the Executive Committee, International Medical and Scientific Board of The Multiple Sclerosis International Federation (MSIF), and the Board of European Charcot Foundation (ECF). He is an inaugural member and Deputy Secretary of Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS) and an honorary member of The Association of Sri Lankan Neurologists (Honorary Member, 2012), Indian Academy of Neurology (Honorary Corresponding Member, 2015) and Hong Kong Society of Multiple Sclerosis (Honorary Fellow, 2015).

Maria José Sá

Maria José Sá graduated in Medicine in 1976 and obtained a Ph.D. degree in 1998 from the Faculty of Medicine of the University of Porto.  She is a Senior Neurologist in the Department of Neurology of Centro Hospitalar São João, Porto, where she heads the MS Clinic and the CSF Laboratory.  She is also Associate Professor of Neurology at the Faculty of Health Sciences of the University Fernando Pessoa in Porto.

Main areas of interest are neuroimmunology, biomarkers, and the inflammatory/demyelinating diseases of the nervous system, particularly MS. She is author of many presentations and publications in peer-reviewed journals as well as 7 books and 10 book chapters, and was the coordinator of the main textbook of neurology edited in Portugal “Clinical

Neurology:  Understanding Neurological Diseases” (2nd ed. 2014).

Professor Maria José Sá was president of the first, second and third International Porto MS Congresses (2011; 2013; 2015) and has been involved in national and international organizations (Portuguese Society of Neurology, MS group of Directorate-General of Health, Portuguese Health Ministry). She is a member of the ESNI Scientific Board, the EAN MS Scientific Panel and the International Consortium of Guthy-Jackson Charitable Foundation.

Peter Rieckmann

Professor Peter Rieckmann received his medical degree from the University
of Göttingen, Germany in 1989. After a postdoctoral fellowship in molecular
immunology at the NIH, Bethesda, USA he completed his training in
Neurology at the National Institute for Nervous Disease, London, UK and the
University of Göttingen, Germany. Professor Rieckmann received Board
certification in Neurology in 1995. His academic and clinical positions have
included Senior (staff) Neurologist and Professor for Neurology, Dept. of
Neurology, as well as head of the Clinical Research Group for Multiple
Sclerosis and Neuroimmunology, at the Julius-Maximilians University of
Würzburg.
In 2007 Professor Rieckmann became the MS Society of Canada Research
Chair and Director of the MS Program at the University of British Columbia
and Vancouver Hospital, Canada. Under his leadership the Vancouver
program was awarded Western-Pacific Research and Training Center by the
MS Society of Canada. He is a founding member of the EndMS campaign in
Canada and was instrumental in establishing the concept for the Center for
Brain Health at UBC in Vancouver (http://www.centreforbrainhealth.ca).
His major research interests are biomarkers, disease modifying factors and
regeneration in multiple sclerosis as well as molecular and functional aspects
of the blood brain barrier in neurological diseases. Professor Rieckmann’s
clinical goals include enhancing awareness and education about MS and
stroke, developing effective and properly resourced services for MS outpatient
care, and providing more customized treatments.
As a clinician scientist he has been actively involved in different efforts to
transfer bench results to clinical developments and serves on steering
committees and advisory boards of various investigator initiated MS trials and
international multi-centre studies (Phase II and III).
In September 2009 he has started a new position as Chair of the Department
of Neurology at the Academic Hospital in Bamberg, and Professor of
Neurology at the University of Erlangen, Germany. Since 2012 he also serves
as deputy medical director of the Academic Hospital in Bamberg. In the same
year he started the MS in the 21 st century steering group, a think tank of
international experts and people with MS working on innovative principles of
MS care in the future.

Jennifer Kilian

Professor Peter Rieckmann received his medical degree from the University
of Göttingen, Germany in 1989. After a postdoctoral fellowship in molecular
immunology at the NIH, Bethesda, USA he completed his training in
Neurology at the National Institute for Nervous Disease, London, UK and the
University of Göttingen, Germany. Professor Rieckmann received Board
certification in Neurology in 1995. His academic and clinical positions have
included Senior (staff) Neurologist and Professor for Neurology, Dept. of
Neurology, as well as head of the Clinical Research Group for Multiple
Sclerosis and Neuroimmunology, at the Julius-Maximilians University of
Würzburg.
In 2007 Professor Rieckmann became the MS Society of Canada Research
Chair and Director of the MS Program at the University of British Columbia
and Vancouver Hospital, Canada. Under his leadership the Vancouver
program was awarded Western-Pacific Research and Training Center by the
MS Society of Canada. He is a founding member of the EndMS campaign in
Canada and was instrumental in establishing the concept for the Center for
Brain Health at UBC in Vancouver (http://www.centreforbrainhealth.ca).
His major research interests are biomarkers, disease modifying factors and
regeneration in multiple sclerosis as well as molecular and functional aspects
of the blood brain barrier in neurological diseases. Professor Rieckmann’s
clinical goals include enhancing awareness and education about MS and
stroke, developing effective and properly resourced services for MS outpatient
care, and providing more customized treatments.
As a clinician scientist he has been actively involved in different efforts to
transfer bench results to clinical developments and serves on steering
committees and advisory boards of various investigator initiated MS trials and
international multi-centre studies (Phase II and III).
In September 2009 he has started a new position as Chair of the Department
of Neurology at the Academic Hospital in Bamberg, and Professor of
Neurology at the University of Erlangen, Germany. Since 2012 he also serves
as deputy medical director of the Academic Hospital in Bamberg. In the same
year he started the MS in the 21 st century steering group, a think tank of
international experts and people with MS working on innovative principles of
MS care in the future.

Ana Martins da Silva

SPONSORS

Institutional

Scientific


This congress is endorsed by the EAN